Bowman Cox (@bowmancox) 's Twitter Profile
Bowman Cox

@bowmancox

I write on what’s new in biopharmaceutical manufacturing science, technology, quality and policy.

ID: 817891698

calendar_today11-09-2012 18:04:54

2,2K Tweet

613 Takipçi

574 Takip Edilen

Bowman Cox (@bowmancox) 's Twitter Profile Photo

One wonders if the US COVID-19 vaccine stockpile will outlast vaccine hesitancy as the Delta variant surges. Expiry extensions based on continuing stability testing may help: pink.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

This is turning into an increasingly challenging issue. US FDA Won't Budge On Nitrosamines Compliance Despite Complaints Of Possible Drug Shortages pink.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

Just because FDA can detain imports from red-listed pharmaceutical suppliers at the border doesn't mean it will, necessarily. pink.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

An international approach to flagging falsified medicines is emerging but questions remain about who will pay for it, @ScripIanS reports: How To Set Up A Medicines Traceability System pink.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

A fascinating look from Ian Haydock at the politics around #Taiwan's surprisingly efficacious #COVID19 #vaccine: scrip.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

More from Derrick: Could Sponsors’ Supply Chain Policing Have Caught Alleged CRO Fraud? pink.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

Bourla: Pfizer's other business units want to have "their own COVID moment." pink.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

A dose of reality on the regulatory journey of pediatric mRNA COVID-19 vaccines from Nielsen Hobbs: pink.pharmaintelligence.informa.com/articles/2021/…

Jessica Huseman (@jessicahuseman) 's Twitter Profile Photo

if someone had told me in 2014, when I did not know what FOIA was, that Nieman Lab would be writing a story about a company I started to teach people how to file FOIs I would have asked, "How do you spell foy-ya" and then I would have laughed. niemanlab.org/2021/11/journa…

if someone had told me in 2014, when I did not know what FOIA was, that <a href="/NiemanLab/">Nieman Lab</a> would be writing a story about a company I started to teach people how to file FOIs I would have asked, "How do you spell foy-ya" and then I would have laughed. niemanlab.org/2021/11/journa…
Bowman Cox (@bowmancox) 's Twitter Profile Photo

It's not an inspection, but #FDA just wants to look around? @ShawnMSchmitt reports that emergency use authorization Holders Shouldn’t Be Surprised If FDA Shows Up To Investigate medtech.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

BARDA Lays Out Vision For Next Pandemic: Vaccines For The US Within 130 Days pink.pharmaintelligence.informa.com/articles/2021/…

Bowman Cox (@bowmancox) 's Twitter Profile Photo

#FDA has caught up on OAI follow-up #inspections, Shannon Brown reports. pink.pharmaintelligence.informa.com/articles/2021/…

LinkedIn Help (@linkedinhelp) 's Twitter Profile Photo

It’s not you, it's us! You may be having trouble viewing LinkedIn. Our teams are working to bring us back to your normally scheduled programming as soon as possible.

Derrick (@dgingery) 's Twitter Profile Photo

The latest Pink Sheet, Citeline Regulatory podcast is posted! Listen to Nielsen Hobbs, Bowman Cox and I discuss the AAM conference, FDA under Trump 2.0, and Hill hearings on drug shortages and foreign inspections #pinksheet #pharma: soundcloud.com/citelinesounds…